Adult ADHD Excellence Forum

Adult ADHD

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices

Podcasts

Suicidality Rates Significantly Higher Among People With ADHD

01/22/2021

In this podcast, Esme Fuller-Thomson, PhD, discusses her recent research which showed significantly higher rates of suicide attempt and ideation among people with attention-deficit/hyperactivity disorder (ADHD).

In this podcast, Esme...

01/22/2021

Psych Congress Network

Videos

Dr. Timothy Wilens on the Risks of Stimulant Misuse and Abuse

12/09/2020

Timothy Wilens, MD, of Harvard Medical School discusses the risks associated with misuse and abuse of prescription stimulants.

Timothy Wilens, MD, of Harvard...

12/09/2020

Psych Congress Network

Videos

Limiting the Misuse and Diversion of Prescription Stimulants

11/03/2020

In this video, Timothy Wilens, MD, of Harvard Medical School, discusses strategies for limiting the misuse and diversion of prescription stimulants.

In this video, Timothy Wilens,...

11/03/2020

Psych Congress Network

Videos

Emerging Treatment Approaches for ADHD

10/22/2020

Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).

Psych Congress 2020 cochair...

10/22/2020

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Adult ADHD Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products